Overview

Injection Pen Market is estimated to value over USD 68.2 billion by 2027 end and register a CAGR of over 9% during the forecast period 2020 to 2027.

Injection pens are prefilled syringes that are used to administer drugs into the body. They are commonly used to dispense insulin to diabetic patients as well as for fertility and therapy treatments. They have a number of advantages, namely because they are different from the regular syringe and vial usage. The simple handling, application and maintenance are factors which shall augment the global injection pen market growth further.

The demand for injection pens is anticipated to gain significant traction in the market due to the growing presence of chronic diseases on a global scale, a rise in approvals and sanctions by regulatory bodies, as well as considerable reimbursements. However, the tendency to opt for alternative drug delivery methods and the relatively low reimbursement in developing nations, are factors which could pose hindrances to the market.

The disposable injection pens market is expected to account for the highest CAGR during the forecast time frame. Factors such as user-friendliness, portability and a reduced possibility of infection, is likely to spur the market growth. Going by the basis of therapy, the market for injection pens is divided into, growth hormone therapy, diabetes, fertility, osteoporosis, and other therapies. The high growth of the injection pen segment can be linked to the large population pool and profound reimbursements for diabetes related treatments in developed nations. The diabetes segment is then categorized into GLP-1and insulin.

Major players in the global injection pen market are Ypsomed (Switzerland), Sanofi (France), Owen Mumford (UK), Haselmeier (Switzerland), Merck (US), Becton Dickinson and Company (US), Eli Lilly (US), F.Hoffman-La Roche (Switzerland), AstraZeneca (UK), Pfizer (US), Novartis (Switzerland).

Injection Pen Market Segmentation:

By Dosage Type:

Fixed
Variable

By Application

Diabetes
Insulin
Non-insulin
Anaphylaxis
Osteoporosis
Growth hormone deficiency
Arthritis
Others

By Region

Europe
North America
Asia Pacific
Latin America
Middle East & Africa

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global injection pen market by dosage type, by application, and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions